paricalcitol · Medicine question

What is the mean half-life of intravenous paricalcitol in patients with stage 5 chronic kidney disease requiring haemodialysis?

Name: What is the mean half-life of intravenous paricalcitol in patients with stage 5 chronic kidney disease requiring haemodialysis?
Published: 2026-11-08T14:30:18.059Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Intravenous paricalcitol has a mean half-life of about 15 hours in patients with stage 5 chronic kidney disease requiring haemodialysis.

Sources for this answer

Zemplar 5 microgram/ml Solution for InjectionAbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 24Document updated 3 July 2020

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about paricalcitol